BACKGROUND: Associations between circulating concentrations of oestrogens, progesterone, and androgens with breast cancer and related risk factors in premenopausal women are not well understood. We aimed to characterise these associations with a pooled analysis of data from seven studies. METHODS: Individual participant data for prediagnostic sex hormone and sex hormone-binding globulin (SHBG) concentrations were contributed from seven prospective studies. We restricted analyses to women who were premenopausal and younger than 50 years at blood collection, and to women with breast cancer diagnosed before age 50 years. We estimated odds ratios (ORs) with 95% CIs for breast cancer associated with hormone concentrations by conditional logistic regression in cases and controls matched for age, date of blood collection, and day of cycle, with stratification by study and further adjustment for cycle phase. We examined associations of hormones with risk factors for breast cancer in control women by comparing geometric mean hormone concentrations in categories of these risk factors, adjusted for study, age, phase of menstrual cycle, and body-mass index (BMI). All statistical tests were two-sided. FINDINGS: We included data for up to 767 women with breast cancer and 1699 controls in the risk analyses. Breast cancer risk was associated with a doubling in concentrations of oestradiol (OR 1·19, 95% CI 1·06-1·35), calculated free oestradiol (1·17, 1·03-1·33), oestrone (1·27, 1·05-1·54), androstenedione (1·30, 1·10-1·55), dehydroepiandrosterone sulphate (1·17, 1·04-1·32), testosterone (1·18, 1·03-1·35), and calculated free testosterone (1·08, 0·97-1·21). Breast cancer risk was not associated with luteal phase progesterone (doubling in concentration OR 1·00, 95% CI 0·92-1·09), and adjustment for other factors had little effect on any of these ORs. Cross-sectional analyses in control women showed several associations of sex hormones with breast cancer risk factors. INTERPRETATION: Circulating oestrogens and androgens are positively associated with the risk for breast cancer in premenopausal women.
BACKGROUND: Associations between circulating concentrations of oestrogens, progesterone, and androgens with breast cancer and related risk factors in premenopausal women are not well understood. We aimed to characterise these associations with a pooled analysis of data from seven studies. METHODS: Individual participant data for prediagnostic sex hormone and sex hormone-binding globulin (SHBG) concentrations were contributed from seven prospective studies. We restricted analyses to women who were premenopausal and younger than 50 years at blood collection, and to women with breast cancer diagnosed before age 50 years. We estimated odds ratios (ORs) with 95% CIs for breast cancer associated with hormone concentrations by conditional logistic regression in cases and controls matched for age, date of blood collection, and day of cycle, with stratification by study and further adjustment for cycle phase. We examined associations of hormones with risk factors for breast cancer in control women by comparing geometric mean hormone concentrations in categories of these risk factors, adjusted for study, age, phase of menstrual cycle, and body-mass index (BMI). All statistical tests were two-sided. FINDINGS: We included data for up to 767 women with breast cancer and 1699 controls in the risk analyses. Breast cancer risk was associated with a doubling in concentrations of oestradiol (OR 1·19, 95% CI 1·06-1·35), calculated free oestradiol (1·17, 1·03-1·33), oestrone (1·27, 1·05-1·54), androstenedione (1·30, 1·10-1·55), dehydroepiandrosterone sulphate (1·17, 1·04-1·32), testosterone (1·18, 1·03-1·35), and calculated free testosterone (1·08, 0·97-1·21). Breast cancer risk was not associated with luteal phase progesterone (doubling in concentration OR 1·00, 95% CI 0·92-1·09), and adjustment for other factors had little effect on any of these ORs. Cross-sectional analyses in control women showed several associations of sex hormones with breast cancer risk factors. INTERPRETATION: Circulating oestrogens and androgens are positively associated with the risk for breast cancer in premenopausal women.
Authors: R Kaaks; S Rinaldi; T J Key; F Berrino; P H M Peeters; C Biessy; L Dossus; A Lukanova; S Bingham; K-T Khaw; N E Allen; H B Bueno-de-Mesquita; C H van Gils; D Grobbee; H Boeing; P H Lahmann; G Nagel; J Chang-Claude; F Clavel-Chapelon; A Fournier; A Thiébaut; C A González; J R Quirós; M-J Tormo; E Ardanaz; P Amiano; V Krogh; D Palli; S Panico; R Tumino; P Vineis; A Trichopoulou; V Kalapothaki; D Trichopoulos; P Ferrari; T Norat; R Saracci; E Riboli Journal: Endocr Relat Cancer Date: 2005-12 Impact factor: 5.678
Authors: P Muti; M Trevisan; A Micheli; V Krogh; G Bolelli; R Sciajno; F Berrino Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-11 Impact factor: 4.254
Authors: Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari Journal: Int J Cancer Date: 2019-04-30 Impact factor: 7.396
Authors: Hazel B Nichols; Donna D Baird; Frank Z Stanczyk; Anne Z Steiner; Melissa A Troester; Kristina W Whitworth; Dale P Sandler Journal: Cancer Prev Res (Phila) Date: 2015-04-14
Authors: Vicki Hart; Katherine W Reeves; Susan R Sturgeon; Nicholas G Reich; Lynnette Leidy Sievert; Karla Kerlikowske; Lin Ma; John Shepherd; Jeffrey A Tice; Amir Pasha Mahmoudzadeh; Serghei Malkov; Brian L Sprague Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-27 Impact factor: 4.254
Authors: Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte Journal: Int J Cancer Date: 2018-02-08 Impact factor: 7.396
Authors: A Heather Eliassen; Regina G Ziegler; Lauren C Houghton; Julia S Sisti; Susan E Hankinson; Jing Xie; Xia Xu; Robert N Hoover Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-03-06 Impact factor: 4.254
Authors: Kevin H Kensler; A Heather Eliassen; Bernard A Rosner; Susan E Hankinson; Myles Brown; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2019-01-02 Impact factor: 4.872
Authors: Jun Wang; Xuehong Zhang; Andrew H Beck; Laura C Collins; Wendy Y Chen; Rulla M Tamimi; Aditi Hazra; Myles Brown; Bernard Rosner; Susan E Hankinson Journal: Horm Cancer Date: 2015-09-18 Impact factor: 3.869